237 related articles for article (PubMed ID: 11906757)
21. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
[No Abstract] [Full Text] [Related]
22. Immune responses to Bordetella pertussis infection and vaccination.
Tomoda T; Ogura H; Kurashige T
J Infect Dis; 1991 Mar; 163(3):559-63. PubMed ID: 1995729
[TBL] [Abstract][Full Text] [Related]
23. Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy.
Kent A; Ladhani SN; Andrews NJ; Matheson M; England A; Miller E; Heath PT;
Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27255149
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
[No Abstract] [Full Text] [Related]
25. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
27. Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines.
Asgarian-Omran H; Golara M; Abdolmaleki S; Navabi SS; Alipour H; Khoshnoodi J; Hemmati A; Zarei S; Jeddi-Tehrani M; Shokri F
Infect Dis (Lond); 2016 Feb; 48(2):127-32. PubMed ID: 26439274
[TBL] [Abstract][Full Text] [Related]
28. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
[TBL] [Abstract][Full Text] [Related]
29. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
Isacson J; Trollfors B; Taranger J; Lagergård T
Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057
[TBL] [Abstract][Full Text] [Related]
30. Effect of erythromycin treatment on antibody responses in pertussis.
Granström G; Granström M
Scand J Infect Dis; 1994; 26(4):453-7. PubMed ID: 7984978
[TBL] [Abstract][Full Text] [Related]
31. Serological correlates in whooping cough.
Granström M; Granström G
Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
[TBL] [Abstract][Full Text] [Related]
32. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
[TBL] [Abstract][Full Text] [Related]
33. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Cherry JD; Gornbein J; Heininger U; Stehr K
Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
Gonik B; Puder KS; Gonik N; Kruger M
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
[TBL] [Abstract][Full Text] [Related]
35. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
36. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
[TBL] [Abstract][Full Text] [Related]
37. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of serologic assays for diagnosis of whooping cough.
Granström G; Wretlind B; Salenstedt CR; Granström M
J Clin Microbiol; 1988 Sep; 26(9):1818-23. PubMed ID: 2903178
[TBL] [Abstract][Full Text] [Related]
39. Serum anti-PT and anti-FHA antibody levels, and agglutinin titers after administration of acellular pertussis vaccines.
Kuno-Sakai H; Kimura M; Sato Y; Tsunoda A; Urano T; Isomura S; Kamiya H
Acta Paediatr Jpn; 1989 Apr; 31(2):120-6. PubMed ID: 2516691
[TBL] [Abstract][Full Text] [Related]
40. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
He Q; Tran Minh NN; Edelman K; Viljanen MK; Arvilommi H; Mertsola J
Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
